Get started
Author

Masayuki Isaji

Observed names: Isaji Masayuki, Isaji, Masayuki, M ISAJI, M Isaji, M. Isaji, MASAYUKI ISAJI, Masayuki ISAJI
OpenAlex ID: A5045000792
Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level
2006 · Kenji Katsuno, Yoshikazu Fujimori, et al. · Journal of Pharmacology and Experimental Therapeutics · 268
Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models
2008 · Yoshikazu Fujimori, Kenji Katsuno, et al. · Journal of Pharmacology and Experimental Therapeutics · 228
SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose
2004 · Shigeki Tazawa, Tokuhisa Yamato, et al. · Life Sciences · 204
SGLT2 inhibitors: molecular design and potential differences in effect
2011 · Masayuki Isaji · Kidney International · 104
Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo
1997 · Masayuki Isaji, Hiroshi Miyata, et al. · British Journal of Pharmacology · 100
PDF
Sodium-glucose cotransporter inhibitors for diabetes.
2007 · Masayuki Isaji · PubMed · 87
Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin
2005 · Fumiki Oana, Hiroo Takeda, et al. · Metabolism · 87
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
2015 · Shigeru Nakano, Kenji Katsuno, et al. · Journal of Clinical and Experimental Hepatology · 82
PDF
KGA-2727, a Novel Selective Inhibitor of a High-Affinity Sodium Glucose Cotransporter (SGLT1), Exhibits Antidiabetic Efficacy in Rodent Models
2012 · Toshihide Shibazaki, Masaki Tomae, et al. · Journal of Pharmacology and Experimental Therapeutics · 80
Selective inhibition of collagen accumulation by N-(3, 4-dimethoxycinnamoyl)anthranilic acid (N-5') in granulation tissue
1987 · Masayuki Isaji, Misao Nakajoh, et al. · Biochemical Pharmacology · 79
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats
2009 · Yoshikazu Fujimori, Kenji Katsuno, et al. · European Journal of Pharmacology · 70
Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes
1989 · Watanabe Takafumi, Horie Shuichi, et al. · Biochemical Pharmacology · 51
Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation
2017 · Toshihiro Inoue, Masaaki Takemura, et al. · European Journal of Pharmacology · 48
Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes anf functions of fibroblasts in vitro
1994 · Masayuki Isaji, Norisato Aruga, et al. · Life Sciences · 46
A novel Syk family kinase inhibitor: Design, synthesis, and structure–activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives
2008 · Akihito Hirabayashi, Harunobu Mukaiyama, et al. · Bioorganic & Medicinal Chemistry · 40
Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a β3-adrenoceptor agonist
2005 · Fumiki Oana, Hiroo Takeda, et al. · European Journal of Pharmacology · 35
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-Ay mice
2009 · Kenji Katsuno, Yoshikazu Fujimori, et al. · European Journal of Pharmacology · 34
Structure–activity relationship studies of imidazo[1,2-c]pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors
2008 · Akihito Hirabayashi, Harunobu Mukaiyama, et al. · Bioorganic & Medicinal Chemistry · 34
Tranilast: A New Application in the Cardiovascular Field as An Antiproliferative Drug
1998 · Masayuki Isaji, Hiroshi Miyata, et al. · Cardiovascular Drug Reviews · 32
PDF
Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout
2016 · Kazuya Tatani, Masahiro Hiratochi, et al. · Journal of Medicinal Chemistry · 26
Effect of Cabergoline, a Long-Acting Dopamine D2 Agonist, on Reserpine-Treated Rodents.
1996 · Masaharu MIYAGI, Nobuhiko ARAI, et al. · Biological and Pharmaceutical Bulletin · 25
PDF
Inhibitory Effects of Tranilast on the Proliferation and Functions of Human Pterygium-derived Fibroblasts
2000 · Masayuki Isaji, Shinji Kikuchi, et al. · Cornea · 24
Structure–activity relationship studies of 5-benzylaminoimidazo[1,2-c]pyrimidine-8-carboxamide derivatives as potent, highly selective ZAP-70 kinase inhibitors
2008 · Akihito Hirabayashi, Harunobu Mukaiyama, et al. · Bioorganic & Medicinal Chemistry · 23
Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides
2012 · Masahiro Hiratochi, Kazuya Tatani, et al. · European Journal of Pharmacology · 22
Differential effects of three dopamine receptor agonists in MPTP-treated monkeys
1995 · N. Arai, M. Isaji, et al. · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · 22
Works count: 52
Citation count: 2,105
H-index: 23
I10-index: 38
Year
Topic
Type